Lbp Am Sa Has $5.67 Million Position in CME Group Inc. $CME

Lbp Am Sa lifted its position in CME Group Inc. (NASDAQ:CME) by 208.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 20,989 shares of the financial services provider’s stock after purchasing an additional 14,189 shares during the quarter. Lbp Am Sa’s holdings in CME Group were worth $5,671,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Caldwell Trust Co grew its stake in CME Group by 116.3% during the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after buying an additional 50 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new position in shares of CME Group in the third quarter valued at approximately $27,000. Financial Consulate Inc. acquired a new position in shares of CME Group in the 3rd quarter worth approximately $28,000. Sagard Holdings Management Inc. bought a new stake in CME Group during the 2nd quarter worth approximately $30,000. Finally, Corundum Trust Company INC acquired a new stake in CME Group during the 3rd quarter valued at $30,000. 87.75% of the stock is owned by institutional investors.

CME Group Price Performance

NASDAQ CME opened at $284.05 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $102.43 billion, a price-to-earnings ratio of 27.52, a PEG ratio of 3.20 and a beta of 0.27. The business has a 50 day simple moving average of $274.27 and a 200 day simple moving average of $271.98. CME Group Inc. has a 52-week low of $232.32 and a 52-week high of $290.79.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 30th. Investors of record on Friday, December 12th were issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Friday, December 12th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Analyst Ratings Changes

CME has been the topic of a number of recent analyst reports. TD Cowen raised CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $310.00 to $318.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $256.00 to $262.00 and gave the stock an “underweight” rating in a report on Thursday, January 22nd. UBS Group reiterated a “neutral” rating on shares of CME Group in a research report on Tuesday, January 6th. Finally, Raymond James Financial increased their price target on shares of CME Group from $307.00 to $311.00 and gave the company an “outperform” rating in a research note on Monday, January 5th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $292.18.

Insider Activity at CME Group

In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of the company’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $263.53, for a total transaction of $263,530.00. Following the completion of the transaction, the director directly owned 1,091 shares of the company’s stock, valued at $287,511.23. This represents a 47.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William R. Shepard acquired 251 shares of the firm’s stock in a transaction that occurred on Tuesday, December 30th. The shares were purchased at an average price of $278.37 per share, with a total value of $69,870.87. Following the completion of the acquisition, the director owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This represents a 0.10% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.30% of the stock is currently owned by insiders.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.